A Look at Supply Chain for Scale Up

Publication
Article
BioPharm InternationalManufacturing and Facilities, November 2023 eBook
Volume 2023 eBook
Issue 4
Pages: 12

Taking a brief status check on the biologics supply chain and any impact on scale up operations.

In speaking with Suzanne Aldington, senior principal scientist, Downstream Processing, Biologics, and Lucas Lin, senior principal scientist, Global Process Development Implementation, Biologics, both at Lonza, BioPharm International® took a pulse on the supply chain lifeline for biologics in the post-pandemic setting. Discussion revolved around any impact the current state of the supply chain may be imparting on scale-up activities in downstream bioprocessing.

Read this article in BioPharm International®’s Manufacturing and Facilities 2023 eBook.

About the author

Feliza Mirasol is the science editor for BioPharm International.

Article details

BioPharm International
eBook: Manufacturing and Facilities 2023
November 2023
Page: 12

Citation

When referring to this article, please cite it as Mirasol, F. A Look at Supply Chain for Scale Up. BioPharm International’s Manufacturing and Facilities 2023 eBook. November 2023.

Recent Videos
David Fairen-Jimenez
Industry Outlook 2025: The Rising Prominence of AI in Pharma
William K. Oh, MD
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Eswar Iyer, Aikium Inc.
Leroy (Lee) Hood, MD, PhD
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
© 2025 MJH Life Sciences

All rights reserved.